Plasma Exchange in a Case of Autoimmune Hemolytic Anemia with Temporary Evan’s Syndrome

Author(s):  
H. Mönch ◽  
R. Lynen ◽  
J. -H. Beyer ◽  
C. Mueller-Eckhardt
Vox Sanguinis ◽  
1987 ◽  
Vol 52 (4) ◽  
pp. 298-300 ◽  
Author(s):  
H. Keyserlingk ◽  
W. Meyer-Sabellek ◽  
R. Arntz ◽  
H. Haller

2020 ◽  
Vol 4 (8) ◽  
pp. 1756-1759
Author(s):  
Maverick Chan ◽  
William K. Silverstein ◽  
Anna Nikonova ◽  
Katerina Pavenski ◽  
Lisa K. Hicks

Key Points Bendamustine can cause severe autoimmune hemolytic anemia (AIHA), which may require plasma exchange and aggressive immunosuppression. Bendamustine-induced AIHA can be delayed, and many, but not all, cases report prior exposure to fludarabine.


1980 ◽  
Vol 78 (3) ◽  
pp. 576-578 ◽  
Author(s):  
Jerome B. Orlin ◽  
Eugene M. Berkman ◽  
Daniel S. Matloff ◽  
Marshall M. Kaplan

Vox Sanguinis ◽  
1987 ◽  
Vol 52 (4) ◽  
pp. 298-300 ◽  
Author(s):  
H. von Keyserlingk ◽  
W. Meyer-Sabellek ◽  
R. Arntz ◽  
H. Haller

1981 ◽  
Vol 15 ◽  
pp. 582-582
Author(s):  
J Lawrence Naiman ◽  
Mark L Bernstein ◽  
Barbara K Schneider

1981 ◽  
Vol 98 (5) ◽  
pp. 774-775 ◽  
Author(s):  
Mark L. Bernstein ◽  
Barbara K. Schneider ◽  
J. Lawrence Naiman

2020 ◽  
Author(s):  
Jiawen Deng

AbstractAutoimmune hemolytic anemia (AIHA) is a rare blood disorder that results in hemolysis of red blood cells (RBCs) due to the presence of autoantibodies in the serum. Previous research has shown that the use of therapeutic plasma exchange therapy (TPE) may be effective at treating AIHA by removing autoimmune antibodies from the intravascular space. However, very little knowledge synthesis is available on the use of TPE in AIHA patients due to the rarity of the disease. We propose a meta-analysis that investigates whether the use of TPE, with or without concurrent treatment regimens, can decrease adverse events, increase remission rate and improve lab results including hemoglobin, RBC, reticulocyte counts, hematocrit and total bilirubin.


Transfusion ◽  
2017 ◽  
Vol 57 (6) ◽  
pp. 1336-1336 ◽  
Author(s):  
Waseem Anani ◽  
Jean Wucinski ◽  
Lisa Baumann Kreuziger ◽  
Jerome Gottschall ◽  
Matthew Karafin

Reumatismo ◽  
2021 ◽  
Vol 72 (4) ◽  
pp. 247-251
Author(s):  
N. Belfeki ◽  
A. Strazzulla ◽  
P. Isnard ◽  
S. Hamrouni ◽  
B. Maamar ◽  
...  

An association of autoimmune hemolytic anemia with disseminated tuberculosis is an exceedingly rare entity. We describe herein a case of cold hemolytic autoimmune anemia associated with miliary tuberculosis resolved with blood transfusions, therapeutic plasma exchange, and antituberculous agents. We discuss the advantages of therapeutic plasma exchange at an early stage in the management of this condition.


Sign in / Sign up

Export Citation Format

Share Document